{
    "organizations": [],
    "uuid": "04e07e3d83e44af7566e64707e32d7256392e2ea",
    "author": "",
    "url": "https://www.reuters.com/article/brief-contravir-pharma-completes-renal-i/brief-contravir-pharma-completes-renal-impairment-study-with-txl-idUSFWN1PW0AR",
    "ord_in_thread": 0,
    "title": "BRIEF-Contravir Pharma Completes Renal Impairment Study With TXL",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 08 AM / in 2 minutes BRIEF-Contravir Pharma Completes Renal Impairment Study With TXL Reuters Staff \nFeb 6 (Reuters) - Contravir Pharmaceuticals Inc: \n* CONTRAVIR PHARMACEUTICALS COMPLETES RENAL IMPAIRMENT STUDY WITH TXL Source text for Eikon: Further company coverage:",
    "published": "2018-02-06T13:08:00.000+02:00",
    "crawled": "2018-02-06T13:22:20.014+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "minute",
        "pharma",
        "completes",
        "renal",
        "impairment",
        "study",
        "txl",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "contravir",
        "pharmaceutical",
        "inc",
        "contravir",
        "pharmaceutical",
        "completes",
        "renal",
        "impairment",
        "study",
        "txl",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}